All Stories

  1. Drastic alterations in the loop structure around colchicine upon complex formation with an engineered lipocalin indicate a conformational selection mechanism
  2. Proline/alanine-rich sequence (PAS) polypeptides as an alternative to PEG precipitants for protein crystallization
  3. An engineered lipocalin that tightly complexes the plant poison colchicine for use as antidote and in bioanalytical applications
  4. Selection of an Anticalin® against the membrane form of Hsp70 via bacterial surface display and its theranostic application in tumour models
  5. The polypeptide biophysics of proline/alanine-rich sequences (PAS): Recombinant biopolymers with PEG-like properties
  6. Anticalins directed against vascular endothelial growth factor receptor 3 (VEGFR-3) with picomolar affinities show potential for medical therapy and in vivo imaging
  7. The Menagerie of Human Lipocalins: A Natural Protein Scaffold for Molecular Recognition of Physiological Compounds
  8. The dimeric crystal structure of the human fertility lipocalin glycodelin reveals a protein scaffold for the presentation of complex glycans
  9. High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation
  10. The Strep-tag System for One-Step Affinity Purification of Proteins from Mammalian Cell Culture
  11. Design and Characterization of a Modular Membrane Protein Anchor to Functionalize the Moss Physcomitrella patens with Extracellular Catalytic and/or Binding Activities
  12. Structure of dimeric human glycodelin
  13. ANTICALINS ® & PASYLATION ® : NEW CONCEPTS FOR BIOPHARMACEUTICAL DRUG DEVELOPMENT FROM PROTEIN DESIGN
  14. 73
  15. Enhanced in vivo efficacy of a long-life type I Interferon superagonist in a mouse model of multiple sclerosis
  16. PAS-cal: A repetitive peptide sequence calibration standard for MALDI mass spectrometry
  17. Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis
  18. Non-Antibody Scaffolds as Alternative Therapeutic Agents
  19. A Fab fragment directed against the neural cell adhesion molecule L1 enhances functional recovery after injury of the adult mouse spinal cord
  20. PAS-cal: a Generic Recombinant Peptide Calibration Standard for Mass Spectrometry
  21. Derivatization of Antibody Fab Fragments: A Designer Enzyme for Native Protein Modification
  22. Biochemical Analysis of Recombinant AlkJ from Pseudomonas putida Reveals a Membrane-Associated, Flavin Adenine Dinucleotide-Dependent Dehydrogenase Suitable for the Biosynthetic Production of Aliphatic Aldehydes
  23. A Photoswitchable Neurotransmitter Analogue Bound to Its Receptor
  24. Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin
  25. Crystal structure of bovine butyrophilin
  26. 113
  27. Coupled Enzymatic Alcohol-to-Amine Conversion of Isosorbide using Engineered Transaminases and Dehydrogenases
  28. Crystallographic analysis and structure-guided engineering of NADPH-dependentRalstoniasp. Alcohol dehydrogenase toward NADH cosubstrate specificity
  29. Combinatorial Design of an Anticalin Directed against the Extra-Domain B for the Specific Targeting of Oncofetal Fibronectin
  30. Crystal structure of the ω-aminotransferase from Paracoccus denitrificans and its phylogenetic relationship with other class III amino- transferases that have biotechnological potential
  31. Deactivation of the E. coli pH Stress Sensor CadC by Cadaverine
  32. β-Barrel scaffolds for the grafting of extracellular loops from G-protein-coupled receptors
  33. Intravenous application of an anticalin dramatically lowers plasma digoxin levels and reduces its toxic effects in rats
  34. The crystal structure of human α 1 -microglobulin reveals a potential haem-binding site
  35. High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneum
  36. NMR Structure of Lipoprotein YxeF from Bacillus subtilis Reveals a Calycin Fold and Distant Homology with the Lipocalin Blc from Escherichia coli
  37. Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting
  38. Half-Life Extension of Therapeutic Proteins via Genetic Fusion to Recombinant PEG Mimetics
  39. Anticalins
  40. Amination of Ketones by Employing Two New (S)-Selective ω-Transaminases and the His-Tagged ω-TA from Vibrio fluvialis
  41. A Disulfide-Free Single-Domain VL Intrabody with Blocking Activity towards Huntingtin Reveals a Novel Mode of Epitope Recognition
  42. Detection of irradiation-induced, membrane heat shock protein 70 (Hsp70) in mouse tumors using Hsp70 Fab fragment
  43. Biosynthesis of a Fluorescent Protein with Extreme Pseudo-Stokes Shift by Introducing a Genetically Encoded Non-Natural Amino Acid outside the Fluorophore
  44. Crystal structure of the sensory domain of Escherichia coli CadC, a member of the ToxR‐like protein family
  45. Structural and biochemical analyses reveal a monomeric state of the bacterial lipocalin Blc
  46. Periplasmic Chaperones Used to Enhance Functional Secretion of Proteins in E. coli
  47. Engineering of an Orthogonal Aminoacyl-tRNA Synthetase for Efficient Incorporation of the Non-natural Amino Acid O-Methyl-L-tyrosine using Fluorescence-based Bacterial Cell Sorting
  48. Incorporation of extra-domain B into fibronectin mediates local dimerization
  49. Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel
  50. High-throughput Sorting of an Anticalin Library via EspP-mediated Functional Display on the Escherichia coli Cell Surface
  51. 757 Endoplasmic Reticulum Stress Responses Contribute to the Cytotoxic Phenotype of CD8αβ Intraepithelial Lymphocytes Through the Regulation Granzyme B Activity in Crohn's Disease-Like TNFΔ are Mice
  52. Ifn gamma inhibits Wnt signaling during colitis.
  53. Purification and Characterization of His-Tagged Antibody Fragments
  54. Purification and Analysis of Strep-tagged Antibody-Fragments
  55. Selection of Antibody Fragments by Means of the Filter-Sandwich Colony Screening Assay
  56. A new crystal form of human tear lipocalin reveals high flexibility in the loop region and induced fit in the ligand cavity
  57. NMR Structure and Dynamics of the Engineered Fluorescein-Binding Lipocalin FluA Reveal Rigidification of β-Barrel and Variable Loops upon Enthalpy-Driven Ligand Binding
  58. Engineered protein scaffolds as next-generation antibody therapeutics
  59. High-Affinity Recognition of Lanthanide(III) Chelate Complexes by a Reprogrammed Human Lipocalin 2
  60. Glutathione S-transferase can be used as a C-terminal, enzymatically active dimerization module for a recombinant protease inhibitor, and functionally secreted into the periplasm of Escherichia coli
  61. The 1.8-Å Crystal Structure of α1-Acid Glycoprotein (Orosomucoid) Solved by UV RIP Reveals the Broad Drug-Binding Activity of This Human Plasma Lipocalin
  62. Identification of potential substrate proteins for the periplasmic Escherichia coli chaperone Skp
  63. Structure of Lumazine Protein, an Optical Transponder of Luminescent Bacteria
  64. DNA vaccination efficiently induces antibodies to Nogo-A and does not exacerbate experimental autoimmune encephalomyelitis
  65. Structural analysis of theL-alanoyl-D-glutamate endopeptidase domain ofListeriabacteriophage endolysin Ply500 reveals a new member of the LAS peptidase family
  66. The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops
  67. Alternative binding proteins get mature: Rivalling antibodies
  68. Alternative binding proteins: Anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities
  69. The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site
  70. Tailoring Protein Scaffolds for Ligand Recognition
  71. Alternative non-antibody scaffolds for molecular recognition
  72. The Crystal Structure of the Human (S100A8/S100A9)2 Heterotetramer, Calprotectin, Illustrates how Conformational Changes of Interacting α-Helices Can Determine Specific Association of Two EF-hand Proteins
  73. Anticalins®: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies
  74. The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins
  75. Biochemical characterization of the recombinant human Nogo-A ectodomain
  76. Epitope mapping of the neuronal growth inhibitor Nogo-A for the Nogo receptor and the cognate monoclonal antibody IN-1 by means of the SPOT technique
  77. The Crystal Structure of the Bacteriophage PSA Endolysin Reveals a Unique Fold Responsible for Specific Recognition of Listeria Cell Walls
  78. Comparative ligand-binding analysis of ten human lipocalins
  79. Rational engineering of a fluorescein-binding anticalin for improved ligand affinity
  80. Anticalins as an alternative to antibody technology
  81. Biochemistry in 2004
  82. Anticalins in Drug Development
  83. Structure of the periplasmic chaperone Skp suggests functional similarity with cytosolic chaperones despite differing architecture
  84. Binding proteins from alternative scaffolds
  85. A Novel Method for the N-Terminal Modification of Native Proteins
  86. Construction of an Artificial Receptor Protein (“Anticalin”) Based on the Human Apolipoprotein D
  87. Crystallographic analysis of an “anticalin” with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region
  88. Structural Mechanism of Specific Ligand Recognition by a Lipocalin Tailored for the Complexation of Digoxigenin
  89. Generation of anticalins with specificity for a nonsymmetric phthalic acid ester
  90. Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant — a so-called ‘anticalin’ — using a molecular random approach
  91. proBA complementation of an auxotrophic E. coli strain improves plasmid stability and expression yield during fermenter production of a recombinant antibody fragment
  92. ‘Anticalins’: a new class of engineered ligand-binding proteins with antibody-like properties
  93. Purification and Characterisation of His-Tagged Antibody Fragments
  94. Purification and Analysis of Strep-Tagged Antibody-Fragments
  95. Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E‐3M2H
  96. Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin orE-3M2H
  97. Lipocalins as a scaffold
  98. Engineered protein scaffolds for molecular recognition
  99. A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin11Edited by R. Huber
  100. Engineered protein scaffolds for molecular recognition
  101. [18] Use of the Strep- tag and streptavidin for detection and purification of recombinant proteins
  102. Applications of a peptide ligand for streptavidin: the Strep-tag
  103. Use of Thiophilic Adsorption Chromatography for the One-Step Purification of a Bacterially Produced Antibody Fab Fragment without the Need for an Affinity Tag
  104. Rapid expression cloning of human immunoglobulin Fab fragments for the analysis of antigen specificity of B cell lymphomas and anti-idiotype lymphoma vaccination
  105. Intracellular Expression of a Cloned Antibody Fragment Interferes with Hepatitis B Virus Surface Antigen Secretion
  106. Immobilization of histidine-tagged proteins on gold surfaces using chelator thioalkanes
  107. Cloning, bacterial synthesis, and characterization of immunoglobulin variable regions of a monoclonal antibody specific for the hepatitis B virus X protein
  108. Use of an albumin-binding domain for the selective immobilisation of recombinant capture antibody fragments on ELISA plates
  109. Sequence analysis and bacterial production of the anti-c-myc antibody 9E10: the VH domain has an extended CDR-H3 and exhibits unusual solubility
  110. The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab Fragment
  111. The Escherichia Coli-Derived Fab Fragment of the IgM/κ Antibody IN-1 Recognizes and Neutralizes Myelin-Associated Inhibitors of Neurite Growth
  112. A Zn(II)-binding site engineered into retinol-binding protein exhibits metal-ion specificity and allows highly efficient affinity purification with a newly designed metal ligand
  113. Molecular Interaction Between the Strep-tag Affinity Peptide and its Cognate Target, Streptavidin
  114. Fermenter production of an artificial fab fragment, rationally designed for the antigen cystatin, and its optimized crystallization through constant domain shuffling
  115. Engineered Fv Fragments as a Tool for the One-Step Purification of Integral Multisubunit Membrane Protein Complexes
  116. Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment in Escherichia coli
  117. Grafting of a High-Affinity Zn(II)-Binding Site on the .beta.-Barrel of Retinol-Binding Protein Results in Enhanced Folding Stability and Enables Simplified Purification
  118. One-step affinity purification of bacterially produced proteins by means of the “Strep tag” and immobilized recombinant core streptavidin
  119. The de Novo Design of an Antibody Combining Site
  120. A general vector, pASK84, for cloning, bacterial production, and single-step purification of antibody Fab fragments
  121. The bilin-binding protein of Pieris brassicae. cDNA sequence and regulation of expression reveal distinct features of this insect pigment protein
  122. Single-step purification of a bacterially expressed antibody Fv fragment by immobilized metal affinity chromatography in the presence of betaine
  123. Functional Expression of the Uncomplexed Serum Retinol-binding Protein in Escherichia coli
  124. Bacterial expression of immunoglobulin fragments
  125. The random peptide library-assisted engineering of a C-terminal affinity peptide, useful for the detection and purification of a functional Ig Fv fragment
  126. Phosphorothioate primers improve the amplification of DNA sequences by DNA polymerases with proofreading activity
  127. Filter screening of antibody Fab fragments secreted from individual bacterial colonies: Specific detection of antigen binding with a two-membrane system
  128. Colony assays for antibody fragments expressed in bacteria
  129. The Functional Expression of Antibody Fv Fragments in Ischhuchia coli: Improved Vectors and a Generally Applicable Purification Technique
  130. Secretion and in vivo folding of the F ab fragment of the antibody McPC603 in Escherichia coli : influence of disulphides and cis -prolines
  131. Structural features of the McPC603 Fabfragment not defined in the X-ray structure
  132. [34] Expression of functional antibody Fv and Fab fragments in Escherichia coli
  133. Structure and Dynamics of One Dimensional Ionic Solutions in Narrow Transmembrane Channels — A Molecular Dynamics Simulation Study —
  134. Non-Antibody Scaffolds